Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
303 studies found for:    Open Studies | "Kidney Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
Condition: Advanced Non-Clear Cell Kidney Cancer
Interventions: Drug: Bevacizumab;   Drug: Atezolizumab
22 Recruiting Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT
Conditions: Cystic Renal Diseases;   Kidney Neoplasms
Interventions: Other: Blood/urine sampling;   Other: Conventional routine CT examination;   Other: Contrast-enhanced renal ultrasonography (CEUS);   Other: Functional MRI
23 Recruiting PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI
Condition: Metastatic Renal Cancer
Intervention: Drug: Prednisone + Everolimus
24 Recruiting Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer
Condition: Renal Cell Carcinoma
Interventions: Biological: High Dose IL-2;   Radiation: SBRT
25 Recruiting Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
Condition: Renal Cancer
Interventions: Behavioral: (EORTC QLQ-C30) questionnaire;   Behavioral: EuroQol EQ-5D 7-item questionnaire
26 Recruiting Safety and Feasibility of IRE for SRMs
Condition: Kidney Cancer
Intervention: Device: Irreversible Electroporation
27 Recruiting Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer
Conditions: Clear Cell Renal Cancer;   Circulating Tumor Cells;   Circulating Endothelial Cells;   Prognostic Biomarkers;   Predictive Biomarkers
Intervention: Other: None- observational study
28 Recruiting Everolimus Modulation of Anti-tumor T CD4 Immune Responses
Condition: Metastatic Renal Cancer
Intervention: Other: Biological samples
29 Recruiting Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma
Conditions: Kidney Neoplasms;   Metastatic Renal Cell Cancer
Intervention: Drug: Sunitinib
30 Recruiting IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)
Conditions: Clear-cell Metastatic Renal Cell Carcinoma;   Kidney Neoplasms
Intervention: Procedure: Molecular imaging
31 Recruiting Pilot Study of Presurgical Tremelimumab With or Without Cryoablation in Patients With Metastatic Renal Cell Carcinoma (RCC)
Condition: Kidney Cancer
Interventions: Drug: Tremelimumab;   Procedure: Cryoablation;   Behavioral: Long-Term Follow-Up
32 Recruiting Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
Condition: Kidney Cancer
Interventions: Drug: Pazopanib;   Drug: Temsirolimus;   Behavioral: Quality of Life Assessment;   Drug: Benadryl
33 Recruiting Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer
Conditions: Recurrent Renal Cell Carcinoma;   Stage I Renal Cell Cancer;   Stage II Renal Cell Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Procedure: Nephrectomy;   Biological: Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
34 Not yet recruiting Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours
Condition: Renal Cell Carcinoma
Interventions: Radiation: Stereotactic Ablative Body Radiosurgery (SABR);   Drug: Pembrolizumab
35 Not yet recruiting A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer
Condition: Clear Cell Metastatic Renal Cell Carcinoma
Interventions: Drug: Nivolumab;   Drug: Ipilimumab;   Drug: Pazopanib;   Drug: Sunitinib
36 Not yet recruiting Impact of the PRISM-care Multidisciplinary Oncology Program on Secured Drug Intake of Patients With Kidney Cancer
Condition: Metastatic Renal Cell Carcinoma
Intervention: Behavioral: PRISM care program
37 Recruiting Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
Condition: Renal Cancer
Intervention: Drug: 124IcG250
38 Recruiting Metastasectomy Study in Renal Cell Carcinoma (RCC)
Condition: Kidney Cancer
Intervention: Other: Evaluation
39 Recruiting Active Surveillance of the Small Renal Mass
Condition: Small Renal Mass, Kidney Cancer
Intervention:
40 Recruiting Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
Conditions: Prostate Cancer;   Bladder Cancer;   Kidney Cancer
Intervention: Drug: Ferumoxytol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.